Parkinson's disease (PD)
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Aged 18-80 years, no gender limit; 2. According to the standard diagnosis of the brain bank of the British Parkinson's Disease Society, diagnosed as an idiopathic PD patient; 3. Stable dose of anti-Parkinson's disease drug treatment for >= 28 days, and maintain the dose of treatment during the treatment period; 4. The patient or the guardian of patient voluntarily sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Secondary Parkinson's syndrome or Parkinson's superimposed syndrome caused by vascular factors, toxins, drugs, etc.; 2. PD patients with persistent head tremor; 3. Previously received DBS or mutilation; 4. Other contraindications for the use of repeated transcranial magnetic stimulation (such as history of epileptic seizures, pregnant women, installation of cardiac pacemakers, metal implants in the body, intracranial hypertension, severe bleeding tendency, etc.); 5. Those who received rTMS treatment in the past 6 months; 6. After evaluation by the investigator, there are other factors that are not suitable for participating in the study or those who cannot insist on completing the follow-up.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Treg cells; | — |
Countries
China
Contacts
Zhujiang Hospital, Southern Medical University